Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ciprofloxacin/diclofenac/dipyrone

Toxic epidermal necrolysis treated with human gamma globulin: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Pulido-Diaz N, Angulo-Alvarez DM, Lopez-Ibarra M.[Human gamma globulin in toxic epidermal necrolysis]. [Spanish]. Revista Medica el Instituto Mexicano del Seguro Social 50: 59-62, No. 1, Jan 2012 - Mexico

    Download references

    Additional information

    Key words

    Dipyrone; therapeutic use; Diclofenac; Ciprofloxacin; treatment; adverse reactions; drug-induced; Gammaglobulin; Toxic-epidermal-necrolysis

    An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Ciprofloxacin/diclofenac/dipyrone. React. Wkly. 1428, 14 (2012). https://doi.org/10.2165/00128415-201214280-00046

    Download citation

    Keywords

    • Corticosteroid
    • Urinary Tract
    • Urinary Tract Infection
    • Lower Extremity
    • Etiological Factor